FIELD: organic chemistry, medicine, pharmacy. SUBSTANCE: invention relates to a new compound characterizing with the high degree of antagonism with respect to calcium, in particular, neuron-selective antagonism with respect to calcium. Invention relates to compound of the following formula, it salt or hydrate: . In indicated formula Ar means optionally substituted 5-14-membered aromatic ring and so on; ring A represents any ring taken among piperazine, homopiperazine, piperidine and similar ones; ring B represents optionally substituted (C3-14)-hydrocarbon ring and so on; E means a simple bond, group of the formula -CO- and so on; X means a simple bond, oxygen atom and so on; R1 means hydrogen atom, halogen atom, hydroxyl group and similar ones; D1, D2, W1 and W2 have similar or different values and each represents a simple bond or optionally substituted (C1-6)-alkylene chain. EFFECT: improved prophylaxis method, valuable medicinal properties of compounds.
Title | Year | Author | Number |
---|---|---|---|
COMPOUNDS OF N,N-SUBSTITUTED CYCLIC AMINE | 1999 |
|
RU2232156C2 |
PIPERIDINE COMPOUND, METHOD FOR ITS PREPARING, PHARMACEUTICAL COMPOSITION AND METHOD FOR INHIBITION OF SODIUM CHANNELS AND POTASSIUM CHANNELS | 2001 |
|
RU2259365C2 |
NOVEL PYRAZOLE DERIVATIVES | 2022 |
|
RU2816835C1 |
DERIVATIVES OF SUBSTITUTED PYRROLOPYRIDINONE USEFUL AS PHOSPHODIESTERASE INHIBITORS | 2001 |
|
RU2267490C2 |
2-AMINOPYRIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND METHOD FOR THERAPY | 2001 |
|
RU2250898C2 |
2,5-DIOXOIMIDAZOLIN-4-YL METHYLCARBONYL COMPOUNDS, METHOD OF OBTAINING THEM, PHARMACEUTICAL MIXTURES CONTAING THEM AND THIR USE IN MEDICINE PREPARATION | 2003 |
|
RU2326117C2 |
AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF | 1996 |
|
RU2182574C2 |
COMPOUNDS HAVING MUSCARINIC RECEPTOR AGONIST AND BETA-2-ADRENERGIC RECEPTOR AGONIST ACTIVITY | 2016 |
|
RU2709777C2 |
ALKYNYL-SUBSTITUTED HETEROCYCLIC COMPOUND, METHOD FOR PRODUCTION THEREOF AND USE THEREOF IN MEDICINE | 2017 |
|
RU2729069C1 |
NOVEL COUMARIN DERIVATIVES WITH ANTI-TUMOUR ACTIVITY | 2007 |
|
RU2428420C2 |
Authors
Dates
2004-06-10—Published
2001-01-18—Filed